Update on Business Immunity to COVID-19 Lawsuits

by Mike McCully, President of The McCully Group In less than a month following Q1 2018, the dairy markets have awakened. While some expect further gains due to tighter supply-demand conditions, others point to adequate stocks for most products. International…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Mike McCully, President of The McCully Group In less than a month following Q1 2018, the dairy markets have awakened. While some expect further gains due to tighter supply-demand conditions, others point to adequate stocks for most products. International…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Abiomed, Inc. (NYSE: ABMD) is a leader in the percutaneous heart pump device market, having launched its first Impella device in 2008 and have since released four iterations with varying flow rates. From May…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A healthcare team at a leading consulting firm wanted to better understand how anti-cancer pharmaceuticals are evaluated for inclusion on payer formularies. They were conducting strategy research on behalf of a pharmaceutical company. They needed a large…

Read More

Update on Business Immunity to COVID-19 Lawsuits

  CLIENT SITUATION A due diligence team at a leading consulting firm needed to quickly get up to speed on data center storage solutions. To better understand the major players and potential market size for these solutions, they were looking…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Alon Ben Joseph, CEO of Ace Jewelers Group   HOW DID CVC BEAT THE LUXURY GROUPS? In October 2016, rumors started that one of the few independent, family-owned and run watchmaking companies was for sale. Six months later, the…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Kenny Dolgin, Data Insights, Guidepoint Edwards Lifesciences Corp. (NYSE: EW) is a leader in the approximately $3 billion transcatheter heart valve (THV) market, having launched their first SAPIEN valve in the U.S. in 2011 and now having released their…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Charles Moore, President, Premier Products On October 14, 2015 Walmart shocked Wall Street with its worst one-day plunge in 27 years. The shares of the corporate giant dropped 10 percent for a loss of $21.5 billion in market capitalization….

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Charles Moore, President, Premier Products In 1997, U.S. sales of organic food and beverages totaled less than $4 billion, according to the Organic Trade Association. Fast forward to 2014, and the OTA reports organic sales surpassed $35 billion, with…

Read More

Update on Business Immunity to COVID-19 Lawsuits

By Michael P. Fischetti, Executive Director, National Contract Management Association Government contracting is as old as government itself. Two key factors: 1) reduced budgets and 2) more complex contracts, have forced government to learn more about supply chain learning.  …

Read More